$SNBP Panbela Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Panbela Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Panbela Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Panbela Therapeutics, Inc. for free.
CIK Number: 0001029125
IRS Number: 870543922
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SNBP
Company Address: 712 VISTA BLVD #305 WACONIA 55387
Phone number: 9524791196
Former name: CIMARRON SOFTWARE INC, date of change: 1996-12-17
Former name: Cimarron Medical, Inc., date of change: 2015-06-02
Former name: Sun BioPharma, Inc., date of change: 2015-09-11
Market Capitalization: $56.31M
Prev close: $1.75
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.55
Year High: $5.40
Panbela Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 1,000 | 0 | 0 | 1,000 to 0 (-100.00 %) |
Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 3,284 | 0 | 46,284 | 43 K to 46.3 K (+7.64 %) |
Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 7,142 | 0 | 1,000 | 8.1 K to 1,000 (-87.72 %) |
Apr 01 2021 | SNBP | Panbela Therapeuti ... | Simpson Jennifer K. | President and CEO | Option Exercise | A | 4.09 | 170,000 | 695,300 | 170,000 | |
Apr 01 2021 | SNBP | Panbela Therapeuti ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 4.09 | 40,000 | 163,600 | 40,000 | |
Apr 01 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Option Exercise | A | 4.09 | 35,000 | 143,150 | 35,000 | |
Apr 01 2021 | SNBP | Panbela Therapeuti ... | Cullen Michael T. | Executive Chairman | Option Exercise | A | 4.09 | 55,000 | 224,950 | 55,000 | |
Dec 03 2020 | SNBP | Panbela Therapeuti ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 2,875 | 0 | 5,875 | 3 K to 5.9 K (+95.83 %) |
Dec 03 2020 | SNBP | Panbela Therapeuti ... | Schemel Donald Robert | Director | Grant | A | 0.00 | 2,875 | 0 | 92,303 | 89.4 K to 92.3 K (+3.21 %) |
Dec 03 2020 | SNBP | Panbela Therapeuti ... | Fratamico Arthur | Director | Grant | A | 0.00 | 2,875 | 0 | 5,299 | 2.4 K to 5.3 K (+118.61 %) |
Sep 14 2020 | SNBP | Sun BioPharma, Inc ... | Simpson Jennifer K. | President and CEO | Buy | P | 2.74 | 1,000 | 2,737 | 3,424 | 2.4 K to 3.4 K (+41.25 %) |
Sep 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 2.55 | 225 | 574 | 159,420 | 159.2 K to 159.4 K (+0.14 %) |
Sep 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 2.51 | 24,775 | 62,158 | 159,195 | 134.4 K to 159.2 K (+18.43 %) |
Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | P | 4.54 | 2,424 | 11,005 | 2,424 | |
Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Buy | P | 0.00 | 2,424 | 0 | 13,436 | 11 K to 13.4 K (+22.01 %) |